JP2020505440A5 - - Google Patents

Download PDF

Info

Publication number
JP2020505440A5
JP2020505440A5 JP2019557669A JP2019557669A JP2020505440A5 JP 2020505440 A5 JP2020505440 A5 JP 2020505440A5 JP 2019557669 A JP2019557669 A JP 2019557669A JP 2019557669 A JP2019557669 A JP 2019557669A JP 2020505440 A5 JP2020505440 A5 JP 2020505440A5
Authority
JP
Japan
Prior art keywords
group
pharmaceutically acceptable
acceptable salt
compound according
isomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019557669A
Other languages
English (en)
Japanese (ja)
Other versions
JP7237010B2 (ja
JP2020505440A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2018/072088 external-priority patent/WO2018130155A1/zh
Publication of JP2020505440A publication Critical patent/JP2020505440A/ja
Publication of JP2020505440A5 publication Critical patent/JP2020505440A5/ja
Application granted granted Critical
Publication of JP7237010B2 publication Critical patent/JP7237010B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019557669A 2017-01-10 2018-01-10 Hdac6選択的阻害剤およびその製造方法と使用 Active JP7237010B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201710017287.2 2017-01-10
CN201710017287 2017-01-10
PCT/CN2018/072088 WO2018130155A1 (zh) 2017-01-10 2018-01-10 Hdac6选择性抑制剂及其制备方法和应用

Publications (3)

Publication Number Publication Date
JP2020505440A JP2020505440A (ja) 2020-02-20
JP2020505440A5 true JP2020505440A5 (https=) 2021-02-18
JP7237010B2 JP7237010B2 (ja) 2023-03-10

Family

ID=62839715

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019557669A Active JP7237010B2 (ja) 2017-01-10 2018-01-10 Hdac6選択的阻害剤およびその製造方法と使用

Country Status (12)

Country Link
US (1) US10745389B2 (https=)
EP (1) EP3569592B8 (https=)
JP (1) JP7237010B2 (https=)
KR (1) KR102549606B1 (https=)
CN (1) CN110382463B (https=)
AU (1) AU2018208160B2 (https=)
ES (1) ES2927352T3 (https=)
IL (1) IL267968B (https=)
MX (1) MX394624B (https=)
SA (1) SA519402090B1 (https=)
SG (1) SG11201906361YA (https=)
WO (1) WO2018130155A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2961765T3 (es) * 2018-07-04 2024-03-13 Cstone Pharmaceuticals Suzhou Co Ltd Polimorfo del inhibidor selectivo de HDAC6 y su aplicación
JP2022538284A (ja) 2019-06-27 2022-09-01 ザ ジョージ ワシントン ユニバーシティ, ア コングレッショナリー チャータード ノット-フォー-プロフィット コーポレイション Hdac6活性化マクロファージ、その組成物および使用
WO2021110121A1 (zh) * 2019-12-05 2021-06-10 基石药业(苏州)有限公司 Hdac6选择性抑制剂及其组合疗法
MX2022007376A (es) 2019-12-20 2022-09-02 Tenaya Therapeutics Inc Fluoroalqull-oxadiazoles y sus usos.
IL307883A (en) 2021-04-23 2023-12-01 Tenaya Therapeutics Inc HDAC6 inhibitors for use in the treatment of dilated myocardial disease
US20240252502A1 (en) 2021-05-04 2024-08-01 Tenaya Therapeutics, Inc. Hdac6 inhibitors for treatment of metabolic disease and hfpef
WO2024123700A1 (en) * 2022-12-05 2024-06-13 The General Hospital Corporation Histone deacetylase inhibitors
WO2025215092A1 (en) 2024-04-10 2025-10-16 Institut National de la Santé et de la Recherche Médicale Selective hdac6 inhibitors for use in the treatment of myotonic dystrophy type 1

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003209060A1 (en) * 2002-02-07 2003-09-02 Axys Pharmaceuticals, Inc. Assay for acytyltransferase or deacetylase activity
CN101641338A (zh) 2006-09-11 2010-02-03 柯瑞斯公司 作为抗增殖制剂的多功能小分子
CN102123987A (zh) * 2008-07-28 2011-07-13 吉里德科学公司 亚环烷基和亚杂环烷基组蛋白脱乙酰酶抑制剂化合物
WO2011106632A1 (en) * 2010-02-26 2011-09-01 Millennium Pharmaceuticals, Inc. Substituted hydroxamic acids and uses thereof
NZ610225A (en) * 2010-11-16 2015-08-28 Acetylon Pharmaceuticals Inc Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
US8404738B2 (en) * 2011-01-21 2013-03-26 Hoffmann-La Roche Inc. 4-amino-N-hydroxy-benzamides for the treatment of cancer
EP2826769A1 (en) * 2013-07-18 2015-01-21 Institut de Recherche pour le Développement ( IRD) Compounds for the treatment and/or prevention of parasitic diseases and method of production thereof
CA2933907A1 (en) 2013-12-23 2015-07-02 The Trustees Of Columbia University In The City Of New York Selective hdac6 inhibitors
US9464073B2 (en) * 2014-02-26 2016-10-11 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors

Similar Documents

Publication Publication Date Title
JP2020505440A5 (https=)
RU2328486C2 (ru) Производные 2-пиридона в качестве ингибиторов нейтрофильной эластазы
CN114072396A (zh) 作为dna-pk抑制剂的喹啉和噌啉衍生物
JP2012521994A5 (https=)
JP2016515561A5 (https=)
CN112533916A (zh) 一种作用于crbn蛋白的三并环类化合物
RU2015133450A (ru) Соединения имидазопиридина и их применение
JP2014506907A5 (https=)
JP2014507455A5 (https=)
RU2019104899A (ru) Ингибитор ido1 и способ его получения и применение
JP2007530694A5 (https=)
JP2020507589A5 (https=)
JP2013509392A5 (https=)
CN110382463A (zh) Hdac6选择性抑制剂及其制备方法和应用
JP2014502988A5 (https=)
JP2014505017A5 (https=)
JP2015516427A5 (https=)
JP2019516739A5 (https=)
JP2019535723A5 (https=)
JP2020511536A5 (https=)
JP2020504184A5 (https=)
JP2023552610A5 (https=)
JP2016503778A5 (https=)
JP2022526553A5 (https=)
CN110225781A (zh) 噻唑衍生物及其应用